This book systematically assesses the risk of 21 major infectious diseases threatening BRI countries. It consists of 14 chapters. Chapter 1 is an overview. Chapter 2 introduces the history of health cooperation between China and other BRI countries. Chapters 3-14 introduce the prevalence of major infectious diseases threatening BRI countries such as cholera, vaccine preventable diseases (polio, measles, meningitis, Japanese encephalitis, diphtheria, hepatitis A), tuberculosis, influenza, and insect-borne diseases (Dengue fever, Zika virus disease, yellow fever, Chikungunya, Rift Valley fever), plague, malaria, Ebola virus disease, MERS, schistosomiasis, COVID-19 and AIDS, and risk factors, principles and cases of their prevention and control. It is a useful reference book in the research of infectious disease control and prevention, and provides historical experience and lessons learned. It also provides decision support for international cooperation among BRI countries in the field of epidemic prevention and control in the future.

"The Nation has lost sight of its public health goals and has allowed the system of public health to fall into 'disarray'," from The Future of Public Health. This startling book contains proposals for ensuring that public health service programs are efficient and effective enough to deal not only with the topics of today, but also with those of tomorrow. In addition, the authors make recommendations for core functions in public health assessment, policy development, and service assurances, and identify the level of government--federal, state, and local--at which these functions would best be handled.

H1N1 ("swine flu"), SARS, mad cow disease, and HIV/AIDS are a few examples of zoonotic diseases-diseases transmitted between humans and animals. Zoonotic diseases are a growing concern given multiple factors: their often novel and unpredictable nature, their ability to emerge anywhere and spread rapidly around the globe, and their major economic toll on several disparate industries. Infectious disease surveillance systems are used to detect this threat to human and animal health. By systematically collecting data on the occurrence of infectious diseases in humans and animals, investigators can track the spread of disease and provide an early warning to human and animal health officials, nationally and internationally, for follow-up and response. Unfortunately, and for many reasons, current disease surveillance has been ineffective or untimely in alerting officials to emerging zoonotic diseases. Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases assesses some of the disease surveillance systems around the world, and recommends ways to improve early detection and response. The book presents solutions for improved coordination between human and animal health sectors, and among governments and international organizations. Parties seeking to improve the detection and response to zoonotic diseases-including U.S. government and international health policy makers, researchers, epidemiologists, human health clinicians, and veterinarians-can use this book to help curtail the threat zoonotic diseases pose to economies, societies, and health.

The current value of global trade has reached a staggering annual figure of $6 trillion in merchandise crossing borders. Such prolific global trading has, at the same time, begun to raise fears of pandemics and concerns for global health. Yet, investment in public health infrastructure and disease control was never designed to cope with international trade of this volume and diversity. Indeed, most health systems lag far behind, especially in poor countries. This has created new vulnerabilities for global populations to the introduction and amplification of infection through trade. Public fears have been further heightened by frightening news reports of deadly diseases such as Mad Cow disease and E. Coli. Risky Trade: Infectious Disease in the Era of Global Trade provides a thorough examination of the actual risks posed by disease in the age of globalization. Drawing on the economics of international trade and epidemiology, the author explores the critical health issues arising from the enormous increase in global trade and travel. Issues covered include: ¢ The scale of the problem with particular reference to the Sakai outbreak of E. Coli; ¢ Risks from particular microbes - Enteric and viral infections; Highly infectious agents; Antimicrobial resistance; and, Stealth agents; ¢ Global outbreaks as a result of human travel and trade; ¢ Prevention, surveillance and control; ¢ The future health of global trading. In addition to highlighting the problems, the book also addresses some of the potential benefits the same globalization can bring to epidemic control through surveillance, diagnostics, treatment and investigation. The empirical approach ties together existing descriptions and case studies of epidemics building a comprehensive framework for examining new events and considering historical experience with infectious outbreaks. The volume will be a valuable guide to students, academics, practitioners, and policy makers in the areas of international trade, health economics, epidemiology, international/public health and disease control.

In response to the call of the 48th World Health Assembly for a substantial revision of the International Health Regulations, this new edition of the Regulations will enter into force on June 15, 2007. The purpose and scope of the Regulations are "to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade." The Regulations also cover certificates applicable to international travel and transport, and requirements for international ports, airports and ground crossings.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.